These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15800163)
1. Neurotoxicity associated with free valproic acid. Mayerhoff DI; Nurenberg J; Shah S; Schleifer SJ Am J Psychiatry; 2005 Apr; 162(4):810. PubMed ID: 15800163 [No Abstract] [Full Text] [Related]
2. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium. Longo LP Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790 [No Abstract] [Full Text] [Related]
3. Lithium neurotoxicity at normal serum levels. Mesquita J; Cepa S; Silva L; Machado A J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-p.e29-451.e29. PubMed ID: 21037148 [No Abstract] [Full Text] [Related]
4. Valproic acid-induced myopathy in a patient with schizoaffective disorder. Reiche I; Tröger U; Postel SC; Wolf R; Bode-Böger SM J Clin Psychopharmacol; 2009 Aug; 29(4):402-3. PubMed ID: 19593189 [No Abstract] [Full Text] [Related]
11. Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level. Xiong GL; Ferranti J; Leamon MH J Clin Psychopharmacol; 2008 Aug; 28(4):472-3. PubMed ID: 18626286 [No Abstract] [Full Text] [Related]
12. Treatment of valproate-induced hyperammonemia. Stewart JT J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047 [No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of divalproex extended release in psychiatric patients. Jackson RS; Venkataraman S; Atkins RB; Owens M Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629 [No Abstract] [Full Text] [Related]
14. Dose-dependent valproate-induced alopecia in patients with mental disorders. Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968 [TBL] [Abstract][Full Text] [Related]
15. Hyperammonemia associated with valproic acid use in elderly psychiatric patients. Holroyd S; Overdyke JT J Neuropsychiatry Clin Neurosci; 2012; 24(3):372-4. PubMed ID: 23037652 [TBL] [Abstract][Full Text] [Related]
16. A case of valproate-induced encephalopathy. Hong L; Schutz J; Nance M Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383 [No Abstract] [Full Text] [Related]
17. Serum Valproic Acid Levels During Initial Conversion of Antituberculoid Therapy in Bipolar Mania: A Case Report and Literature Review. DeLucia B; Mahon J Psychosomatics; 2017; 58(4):446-449. PubMed ID: 28413090 [No Abstract] [Full Text] [Related]
19. Severe Cognitive Impairment Associated With a High Free But Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient With Bipolar Disorder. Dautzenberg G; Nederlof M; Beekman A; Egberts T; Heerdink ER J Clin Psychopharmacol; 2018 Jun; 38(3):265-268. PubMed ID: 29621091 [No Abstract] [Full Text] [Related]
20. Valproate Intoxication in a Patient With Blood Valproate Levels Within Therapeutic Range. Smits JEMP; Wallenburg E; van Spanje A; van Luin M; Marijnissen RM J Clin Psychiatry; 2017 Apr; 78(4):e413-e414. PubMed ID: 28448701 [No Abstract] [Full Text] [Related] [Next] [New Search]